Most recent by Jessica Philpott, MD, PhD
Most patients with IBD ‘still experience significant challenges’ accessing, affording care
SAN FRANCISCO — Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due to insurance challenges, and many make financial trade-offs to afford care, survey results showed.
Early-life dog ownership may protect against development of Crohn’s disease
SAN DIEGO — Dog ownership and close interactions with these pets in early childhood could help prevent later development of Crohn’s disease, according to data presented at Digestive Disease Week 2022.
Low incidence of SARs-CoV-2 among IBD patients on biologic therapy
Investigators found a low incidence of SARs-CoV-2 among patients with inflammatory bowel disease who were taking biologic therapy, according to recently published data in the Journal of Gastroenterology and Hepatology.
Crohn’s and Colitis Foundation issues guidance on COVID-19 for patients with IBD
The Crohn’s and Colitis Foundation issued guidelines for patients with IBD to protect themselves from COVID-19 such as talk with their gastroenterologist about medications, their health status and any precautions they should take related to COVID-19.